Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A multimodality test to guide the management of patients with a pancreatic cyst.

Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, Afsari B, Li L, Cohen JD, Thompson E, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Simpson RE, Fernandez-Del Castillo C, Mino-Kenudson M, Brugge W, Brand RE, Singhi AD, Scarpa A, Lawlor R, Salvia R, Zamboni G, Hong SM, Hwang DW, Jang JY, Kwon W, Swan N, Geoghegan J, Falconi M, Crippa S, Doglioni C, Paulino J, Schulick RD, Edil BH, Park W, Yachida S, Hijioka S, van Hooft J, He J, Weiss MJ, Burkhart R, Makary M, Canto MI, Goggins MG, Ptak J, Dobbyn L, Schaefer J, Sillman N, Popoli M, Klein AP, Tomasetti C, Karchin R, Papadopoulos N, Kinzler KW, Vogelstein B, Wolfgang CL, Hruban RH, Lennon AM.

Sci Transl Med. 2019 Jul 17;11(501). pii: eaav4772. doi: 10.1126/scitranslmed.aav4772.

PMID:
31316009
2.

Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.

Muroyama Y, Nirschl TR, Kochel CM, Lopez-Bujanda Z, Theodros D, Mao W, Carrera-Haro MA, Ghasemzadeh A, Marciscano AE, Velarde E, Tam AJ, Thoburn CJ, Uddin M, Meeker AK, Anders RA, Pardoll DM, Drake CG.

Cancer Immunol Res. 2017 Nov;5(11):992-1004. doi: 10.1158/2326-6066.CIR-17-0040. Epub 2017 Oct 2.

3.

Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.

Zabransky DJ, Smith HA, Thoburn CJ, Zahurak M, Keizman D, Carducci M, Eisenberger MA, McNeel DG, Drake CG, Antonarakis ES.

Prostate. 2012 Apr;72(5):487-98. doi: 10.1002/pros.21449. Epub 2011 Jul 11.

4.

Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats.

Sharrow AC, Ronnett BM, Thoburn CJ, Barber JP, Giuntoli RL 2nd, Armstrong DK, Jones RJ, Hess AD.

J Ovarian Res. 2010 Mar 31;3:9. doi: 10.1186/1757-2215-3-9.

5.

CD20, AIF-1, and TGF-beta in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies.

Wu JM, Thoburn CJ, Wisell J, Farmer ER, Hess AD.

Mod Pathol. 2010 May;23(5):720-8. doi: 10.1038/modpathol.2010.48. Epub 2010 Feb 26.

6.

Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.

Capriotti E, Vonderheid EC, Thoburn CJ, Wasik MA, Bahler DW, Hess AD.

Leuk Lymphoma. 2008 Jun;49(6):1190-201. doi: 10.1080/10428190802064917.

7.

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing.

Sfanos KS, Bruno TC, Maris CH, Xu L, Thoburn CJ, DeMarzo AM, Meeker AK, Isaacs WB, Drake CG.

Clin Cancer Res. 2008 Jun 1;14(11):3254-61. doi: 10.1158/1078-0432.CCR-07-5164.

8.

Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.

Capriotti E, Vonderheid EC, Thoburn CJ, Bright EC, Hess AD.

J Invest Dermatol. 2007 Dec;127(12):2882-92. Epub 2007 Jun 28.

10.

The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.

Wu JM, Bensen-Kennedy D, Miura Y, Thoburn CJ, Armstrong D, Vogelsang GB, Hess AD.

Biol Blood Marrow Transplant. 2005 Jun;11(6):455-64.

11.

Regulation of OX40 gene expression in graft-versus-host disease.

Miura Y, Thoburn CJ, Bright EC, Arai S, Hess AD.

Transplant Proc. 2005 Jan-Feb;37(1):57-61.

PMID:
15808546
12.

Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.

Hess AD, Thoburn CJ, Miura Y, Bright EC.

Transplant Proc. 2005 Jan-Feb;37(1):53-6.

PMID:
15808545
13.

Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.

Hess AD, Thoburn CJ, Miura Y, Bright EC.

Clin Immunol. 2005 Mar;114(3):307-19.

PMID:
15721842
14.

Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.

Thoburn CJ, Miura Y, Bright EC, Hess AD.

Biol Blood Marrow Transplant. 2004 Sep;10(9):591-603.

15.

Association of Foxp3 regulatory gene expression with graft-versus-host disease.

Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui EC, Matsui WH, Arai S, Fuchs EJ, Vogelsang GB, Jones RJ, Hess AD.

Blood. 2004 Oct 1;104(7):2187-93. Epub 2004 Jun 1.

16.

Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.

Miura Y, Thoburn CJ, Bright EC, Hess AD.

Biol Blood Marrow Transplant. 2004 Mar;10(3):156-70.

17.
19.
20.

Autoimmune-mediated vasculopathy.

Chen W, Thoburn CJ, Miura Y, Sommer M, Hruban R, Qian Z, Baldwin W, Hess AD.

Clin Immunol. 2001 Jul;100(1):57-70.

PMID:
11414746
21.

Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.

Hess AD, Thoburn CJ, Chen W, Horwitz LR.

Biol Blood Marrow Transplant. 2000;6(1):13-24.

22.
23.

Bryostatin can induce antigen-specific nonresponsiveness in human peripheral blood T cells.

Thoburn CJ, Hess AD.

Transplant Proc. 1995 Feb;27(1):443-4. No abstract available.

PMID:
7879055

Supplemental Content

Loading ...
Support Center